Skip to main content
OpenTrials
Completed

NCT Number: NCT00714363

Comparison of LASIK and SBK

The objective of the study is to compare clinical outcomes from LASIK and SBK using FDA-approved laser technology on the same patient

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Utah, John Moran Eye Center

Salt Lake City, Utah, 84132, United States

About this study

Patients undergoing bilateral refractive surgery on the same day will have one eye randomized to LASIK and the fellow eye assigned to SBK treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients deemed to be suitable candidates for bilateral LASIK surgery

Exclusion criteria

  • Patients who desire monovision correction rather than bilateral distance correction

Treatment and study plan

LASIK

Procedure

Refractive surgery

SBK

Procedure

Refractive surgery

Primary outcomes

  1. Visual acuity

    Time frame: 6 months

Secondary outcomes

  1. Manifest refraction

    Time frame: 6 months

  2. Wavefront aberration value

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Registry information

Official study title

Comparison of Laser-Assisted in Situ Keratomeleusis (LASIK) vs Sub-Bowman's Keratomileusis (SBK): Assessment of Visual Function and Patient Satisfaction

Important dates

Study start
2007
Primary completion
2008
Study completion
2010
First posted
Jul 14, 2008
Registry last updated
Oct 19, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.